Hypercalcemia of malignancy
Background
Causes
- PTHrP release
- SCC (particularly of the head and neck), breast renal, endometrial cancer
- Local osteolysis
- Associated primarily with bone mets
- Multiple myeloma, lung, breast cancer
- Production of vitamin D analogues
- Lymphoma (Hodgkin)
Clinical Features
Mnemonic: Stones, Bones, Groans, Moans, Thrones, Psychic Overtones
- "Stones"
- Renal calculi
- Renal failure
- "Bones"
- Bone pain/destruction
- "Groans"
- "Thrones"
- Polyuria/polydipsia (Renal insufficiency)
- Constipation
- "Psychic Overtones"
Differential Diagnosis
Causes of Hypercalcemia
- Addison's disease
- Calciphylaxis
- Excess vitamin D
- Hypercalcemia of malignancy
- Hyperparathyroidism
- Hyperthyroidism
- Hypothyroidism
- Lithium
- Milk-alkali syndrome
- Paget disease
- Sarcoidosis
- Thiazide diuretics
Related to Local Tumor Effects
- Malignant airway obstruction
- Bone metastases and pathologic fractures
- Malignant spinal cord compression
- Malignant Pericardial Effusion and Tamponade
- Superior vena cava syndrome
Related to Biochemical Derangement
- Hypercalcemia of malignancy
- Hyponatremia due to SIADH
- Adrenal insufficiency
- Tumor lysis syndrome
- Carcinoid syndrome
Related to Hematologic Derangement
Related to Therapy
- Chemotherapy-induced nausea and vomiting
- Cytokine release syndrome
- Chemotherapeutic drug extravasation
- Differentiation syndrome (retinoic acid syndrome) in APML
- Stem cell transplant complications
- Catheter-related complications
- Tunnel infection
- Exit site infection
- CVC obstruction (intraluminal or catheter tip thrombosis)
- Catheter-related venous thrombosis
- Fracture of catheter lumen
- Oncologic therapy related adverse events
Evaluation
- Chemistry
- Ionized Ca
- CBC
- LFTs (alk phos, albumin)
- ECG
Management
Asymptomatic or Ca <12 mg/dL
- Does not require immediate treatment
- Advise to avoid factors that can aggravate hypercalcemia (thiazide diuretics, Li, volume depletion, prolonged inactivity, high Ca diet)
Mildly symptomatic Ca 12-14 mg/dL
- May not require immediate therapy; however, an acute rise may cause symptoms necessitating treatment as described for severe hypercalcemia (see below)
Symptomatic or Severe hypercalcemia (Ca >14 mg/dL)
- Patients are likely dehydrated and require saline hydration as initial therapy
Calcitonin
- Consider adding calcitonin 4 units/kg SC or IV q12hr in patients w/ Ca >14 mg/dL (3.5 mmol/L) who are also symptomatic (lowers Ca w/in 2-4hr)
- Tachyphylaxis limits use long term, but is a great choice for emergent cases
Bisphosphonates
Give for severe hypercalcemia due to excessive bone resorption (lowers Ca within 12-48hr)
- Pamidronate 90mg IV over 24 hours OR
- Zoledronate 4mg IV over 15 minutes
- Caution in renal failure, though bisphosphonates have been safely used in pts with pre-existing renal failure[1]
Diuresis
- Furosemide is NOT routinely recommended
- Only consider in patients with renal insufficiency or heart failure and volume overload
Dialysis
Consider if patient:
- Anuric with renal failure
- Failing all other therapy
- Severe hypervolemia not amenable to diuresis
- Serum Calcium level >18mg/dL
- Neurologic symptoms
Corticosteroids
Decrease Ca mobilization from bone and are helpful with steroid-sensitive tumors (e.g. lymphoma, MM)
- Prednisone 60mg PO daily
Disposition
- Ca <12
- Home with follow up if oncology concurs
- Ca>12
- Admit
- ECG changes
- Admit with telemetry
See Also
References
- LeGrand SB et al. Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice. Ann Intern Med. 2008;149:259-263.
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.